Author:
Okyere Joshua,Bediako Vincent Bio,Ackah Josephine Akua,Acheampong Emmanuella,Owusu Bernard Afriyie,Agbemavi Wonder,Nwameme Adanna Uloaku,Kamau Edward Mberu,Asampong Emmanuel
Abstract
Abstract
Background
While Ghana has a good track record in the Expanded Programme on Immunization, there are substantial challenges with regards to subsequent vaccinations, particularly after the first year of life of the child. Given that the last dose of the RTS, S/AS01E vaccine against malaria is administered at 24 months, there is a high likelihood of default. Hence, it is imperative to understand the dynamics and reasons for the defaults to enable the development of effective implementation strategies. This study explored why caregivers default on the RTS, S/AS01E vaccine from the perspective of health service providers and caregivers.
Methods
This study employed an exploratory, descriptive approach. Using a purposive sampling technique, caregivers who defaulted and health service providers directly involved in the planning and delivery of the RTS, S/AS01E vaccine at the district level were recruited. A total of five health service providers and 30 mothers (six per FGD) participated in this study. Data analysis was done using NVivo-12 following Collaizi’s thematic framework for qualitative analysis. The study relies on the Standards for Reporting Qualitative Research.
Results
Reasons for defaulting included the overlap of timing of the last dose and the child starting school, disrespectful attitudes of some health service providers, concerns about adverse side effects and discomforts, travel out of the implementing district, the perception that the vaccines are too many, and lack of support from partners.
Conclusion
To reduce the occurrence of defaulting on the RTS, S/AS01E vaccine programme, stakeholders must reconsider the timing of the last dose of the vaccine. The schedule of the RTS, S/AS01E vaccine should be aligned with the established EPI schedule of Ghana. This will significantly limit the potential of defaults, particularly for the last dose. Also, the findings from this study underscore a need to encourage male partner involvement in the RTS, S/AS01E vaccine programme. Health promotion programmes could be implemented to raise caregivers’ awareness of potential adverse reactions and discomforts—this is necessary to prepare the caregiver for the vaccine process psychologically.
Funder
World Health Organization
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference30 articles.
1. WHO. World Malaria Report. Geneva, World Health Organization. 2016.
2. WHO. Malaria Facts sheet. Geneva, World Health Organization, 2022. https://www.who.int/news-room/fact-sheets/detail/malaria. Accessed Jan 14 2023.
3. Alhassan Y, Dwomoh D, Amuasi SA, Nonvignon J, Bonful H, Tetteh M, et al. Impact of insecticide-treated nets and indoor residual spraying on self-reported malaria prevalence among women of reproductive age in Ghana: implication for malaria control and elimination. Malar J. 2022;21:120.
4. WHO. World malaria report 2019. Geneva: World Health Organization. 2019.
5. RTSS Clinical Trials Partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31–45.